Apollomics Net Receivables vs Non Currrent Assets Other Analysis

APLM Stock   8.16  1.51  15.62%   
Apollomics financial indicator trend analysis is way more than just evaluating Apollomics Class A prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Apollomics Class A is a good investment. Please check the relationship between Apollomics Net Receivables and its Non Currrent Assets Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Net Receivables vs Non Currrent Assets Other

Net Receivables vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Apollomics Class A Net Receivables account and Non Currrent Assets Other. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Apollomics' Net Receivables and Non Currrent Assets Other is 0.96. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Apollomics Class A, assuming nothing else is changed. The correlation between historical values of Apollomics' Net Receivables and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Apollomics Class A are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Net Receivables i.e., Apollomics' Net Receivables and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.96
Relationship DirectionPositive 
Relationship StrengthVery Strong

Net Receivables

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Apollomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Apollomics Class A current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
As of the 26th of November 2024, Tax Provision is likely to grow to about 10.5 K, while Selling General Administrative is likely to drop about 15.7 M.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization681K775K103K97.9K
Interest Income467K431K753K544.8K

Apollomics fundamental ratios Correlations

-0.660.53-0.79-0.020.93-0.970.970.97-0.73-0.971.0-0.860.710.440.390.970.690.71-0.770.38-0.03-0.821.00.73-0.96
-0.66-0.940.760.74-0.80.58-0.81-0.520.220.56-0.620.38-0.97-0.79-0.93-0.75-0.66-0.280.99-0.930.740.37-0.62-0.990.62
0.53-0.94-0.51-0.710.62-0.390.710.330.04-0.390.47-0.20.880.950.850.580.790.35-0.890.85-0.71-0.340.480.91-0.56
-0.790.76-0.510.39-0.890.86-0.82-0.830.760.83-0.80.75-0.84-0.27-0.66-0.87-0.33-0.30.84-0.660.40.52-0.8-0.810.62
-0.020.74-0.710.39-0.33-0.03-0.210.1-0.29-0.090.02-0.27-0.63-0.54-0.93-0.21-0.120.40.63-0.931.0-0.340.02-0.690.0
0.93-0.80.62-0.89-0.33-0.910.930.9-0.65-0.870.93-0.70.80.440.640.990.550.43-0.880.63-0.34-0.580.930.85-0.88
-0.970.58-0.390.86-0.03-0.91-0.92-1.00.871.0-0.980.93-0.67-0.26-0.33-0.95-0.54-0.650.71-0.32-0.020.81-0.98-0.660.86
0.97-0.810.71-0.82-0.210.93-0.920.89-0.62-0.920.95-0.80.850.620.550.960.790.7-0.890.55-0.22-0.80.950.85-0.93
0.97-0.520.33-0.830.10.9-1.00.89-0.88-0.990.98-0.930.610.20.260.940.510.65-0.660.260.09-0.80.980.61-0.87
-0.730.220.040.76-0.29-0.650.87-0.62-0.880.87-0.780.93-0.390.19-0.02-0.69-0.14-0.490.37-0.01-0.280.7-0.77-0.310.54
-0.970.56-0.390.83-0.09-0.871.0-0.92-0.990.87-0.980.96-0.66-0.28-0.28-0.92-0.58-0.720.69-0.27-0.080.87-0.98-0.630.87
1.0-0.620.47-0.80.020.93-0.980.950.98-0.78-0.98-0.880.680.370.350.970.640.7-0.740.350.01-0.821.00.69-0.94
-0.860.38-0.20.75-0.27-0.70.93-0.8-0.930.930.96-0.88-0.54-0.12-0.08-0.77-0.47-0.760.52-0.08-0.260.91-0.88-0.450.71
0.71-0.970.88-0.84-0.630.8-0.670.850.61-0.39-0.660.68-0.540.730.850.770.660.4-0.980.85-0.64-0.510.680.97-0.61
0.44-0.790.95-0.27-0.540.44-0.260.620.20.19-0.280.37-0.120.730.660.430.880.46-0.740.66-0.54-0.380.380.76-0.53
0.39-0.930.85-0.66-0.930.64-0.330.550.26-0.02-0.280.35-0.080.850.660.550.37-0.09-0.871.0-0.93-0.010.350.9-0.34
0.97-0.750.58-0.87-0.210.99-0.950.960.94-0.69-0.920.97-0.770.770.430.550.60.53-0.850.54-0.22-0.680.970.81-0.92
0.69-0.660.79-0.33-0.120.55-0.540.790.51-0.14-0.580.64-0.470.660.880.370.60.82-0.680.37-0.13-0.740.650.66-0.77
0.71-0.280.35-0.30.40.43-0.650.70.65-0.49-0.720.7-0.760.40.46-0.090.530.82-0.38-0.10.39-0.960.70.32-0.71
-0.770.99-0.890.840.63-0.880.71-0.89-0.660.370.69-0.740.52-0.98-0.74-0.87-0.85-0.68-0.38-0.870.640.49-0.74-1.00.71
0.38-0.930.85-0.66-0.930.63-0.320.550.26-0.01-0.270.35-0.080.850.661.00.540.37-0.1-0.87-0.94-0.010.340.9-0.34
-0.030.74-0.710.41.0-0.34-0.02-0.220.09-0.28-0.080.01-0.26-0.64-0.54-0.93-0.22-0.130.390.64-0.94-0.330.01-0.690.01
-0.820.37-0.340.52-0.34-0.580.81-0.8-0.80.70.87-0.820.91-0.51-0.38-0.01-0.68-0.74-0.960.49-0.01-0.33-0.82-0.430.76
1.0-0.620.48-0.80.020.93-0.980.950.98-0.77-0.981.0-0.880.680.380.350.970.650.7-0.740.340.01-0.820.69-0.95
0.73-0.990.91-0.81-0.690.85-0.660.850.61-0.31-0.630.69-0.450.970.760.90.810.660.32-1.00.9-0.69-0.430.69-0.68
-0.960.62-0.560.620.0-0.880.86-0.93-0.870.540.87-0.940.71-0.61-0.53-0.34-0.92-0.77-0.710.71-0.340.010.76-0.95-0.68
Click cells to compare fundamentals

Apollomics Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Apollomics Class A is a strong investment it is important to analyze Apollomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apollomics' future performance. For an informed investment choice regarding Apollomics Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apollomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
0.023
Quarterly Revenue Growth
2.623
Return On Assets
(0.63)
Return On Equity
(1.49)
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apollomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.